Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B virus Co-infection

Xiaoping Chen; Qunqun Jiang; Zhiyong Ma; Jiaxin Ling; Wenjia Hu; Qian Cao; Pingzheng Mo; Rongrong Yang; Shicheng Gao; Xien Gui; Yong Xiong; Jinlin Li; Yongxi Zhang

is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 In early December 2019, there was an outbreak of novel coronavirus-associated pneumonia in Wuhan, China. The virus was spreading rapidly to other cities of China and accumulating cases had been reported in coming days(1). According to the announcement of the World Health Organization (WHO), the disease has been officially named as Coronavirus Disease-2019 (COVID-19) (2). The etiology of the disease was identified to be a novel β-coronavirus, named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on the phylogenetic relationship with SARS-CoV. On March 11, 2020, WHO declared the outbreak of SARS-CoV-2 as a pandemic. So far, more than 290,000 people in over 180 countries or territories have reported COVID-19 cases, and more than 12,000 people have died according to data from WHO (https://www.who.int/emergencies/diseases/novel-coronavirus-2019).